Stock EXPRS2 EXPRES2ION BIOTECH HOLDING AB
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases ExpreS2ion Biotech Holding AB

Equities

EXPRS2

SE0008348262

Market Closed - Nasdaq Stockholm
Other stock markets
 16:29:32 15/05/2024 BST 		5-day change 1st Jan Change
1.44 SEK -0.14% Intraday chart for ExpreS2ion Biotech Holding AB -2.70% -31.75%
04-16 ExpreS2ion Announces Completion of GLP Safety Study for ES2B-C001 (HER2-VLP) Breast Cancer Vaccine Candidate CI
02-21 ExpreS2ion Biotech JV Secures EUR10 Million Following Bavarian Nordic's Completion of COVID-19 Vaccine Trial MT

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
ExpreS2ion to present in spring investor events
AQ
ExpreS2ion Biotech : Annual report 2023 including Auditor’s report
PU
ExpreS2ion annual report for 2023 published
AQ
Notice to attend the Annual General Meeting in ExpreS2ion Biotech Holding AB (publ)
AQ
ExpreS2ion announces a rights issue of units of approximately SEK 60 million
AQ
ExpreS2ion to receive approximately SEK 22.5 million dividend payment from AdaptVac ApS
AQ
ExpreS2ion changes dates for the annual general meeting and the publication of the annual report for 2023
AQ
ExpreS2ion announces completion of GLP safety study for ES2B-C001 (HER2-VLP) breast cancer vaccine candidate
AQ
ExpreS2ion to present in investor and R&D events in March
AQ
ExpreS2ion to present in investor and R&D events in March
AQ
ExpreS2ion's Associated Company AdaptVac Receives Milestone Payment Following Completion of Bavarian Nordic's Clinical Phase III Study for the COVID-19 Vaccine
AQ
ExpreS2ion announces financial results for the fourth quarter and full-year 2023
AQ
ExpreS2ion to present in Redeye Fight Cancer event and the Bio Innovation Leaders Summit
AQ
ExpreS2ion to present new Nipah virus vaccine project in upcoming webcast
AQ
Pareto Securities publishes research report
AQ
ExpreS2ion announces new EU-funded Horizon Europe grant award for Nipah virus vaccine development
AQ
ExpreS2ion CEO interviewed, CFO provides update at life science investor conference, Analysguiden publishes research report
AQ
ExpreS2ion announces financial results for the third quarter 2023
AQ
ExpreS2ion Biotechnologies: Bulletin from the Extraordinary General Meeting of ExpreS2ion Biotech Holding AB held on 9 November 2023
AQ
Background and rationale for the proposed incentive program 2023/2026
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. EXPRS2 Stock
  4. News ExpreS2ion Biotech Holding AB
  5. Press Releases